Prodia Widyahusada Tbk PT Cash Flow Conversion Efficiency

Latest as of June 2025: 0.073x

Prodia Widyahusada Tbk PT cash flow conversion efficiency. Based on the latest financial reports, Prodia Widyahusada Tbk PT (PRDA) has a cash flow conversion efficiency ratio of 0.073x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp169.15 Billion ≈ $9.91 Million USD) by net assets (Rp2.31 Trillion ≈ $135.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Prodia Widyahusada Tbk PT (2013–2024)

Cash flow conversion efficiency of Prodia Widyahusada Tbk PT from 2013 to 2024. This chart illustrates how Prodia Widyahusada Tbk PT's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Prodia Widyahusada Tbk PT (PRDA) stock price for real-time trading data and today's change.

Prodia Widyahusada Tbk PT Cash Flow Conversion Ratio Explained

Prodia Widyahusada Tbk PT cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Prodia Widyahusada Tbk PT Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Prodia Widyahusada Tbk PT ranked by their cash flow conversion efficiency. Also see how much is Prodia Widyahusada Tbk PT worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
PetroVietnam General Services Corp
VN:PET
-0.330x
Chargeurs S.A.
PA:CRI
0.068x
Sweeten Real Estate Development Co Ltd
TW:5525
-0.067x
TCI Express Limited
NSE:TCIEXP
0.026x
Polyram Plastic Industries Ltd
TA:POLP
0.071x
Chen Full International Co Ltd
TWO:8383
-0.006x
Trisul S.A
SA:TRIS3
-0.024x
Ares Commercial Real Estate
NYSE:ACRE
0.014x

Annual Cash Flow Conversion Efficiency for Prodia Widyahusada Tbk PT (2013–2024)

The table below shows the annual cash flow conversion efficiency of Prodia Widyahusada Tbk PT from 2013 to 2024. Review free cash flow generation of Prodia Widyahusada Tbk PT to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Rp2.48 Trillion
≈ $145.59 Million
Rp476.64 Billion
≈ $27.93 Million
0.192x +10.10%
2023-12-31 Rp2.36 Trillion
≈ $138.32 Million
Rp411.29 Billion
≈ $24.10 Million
0.174x -18.94%
2022-12-31 Rp2.31 Trillion
≈ $135.42 Million
Rp496.73 Billion
≈ $29.11 Million
0.215x -37.72%
2021-12-31 Rp2.25 Trillion
≈ $131.98 Million
Rp777.27 Billion
≈ $45.54 Million
0.345x +41.99%
2020-12-31 Rp1.79 Trillion
≈ $104.79 Million
Rp434.63 Billion
≈ $25.47 Million
0.243x +18.00%
2019-12-31 Rp1.66 Trillion
≈ $97.25 Million
Rp341.82 Billion
≈ $20.03 Million
0.206x +34.16%
2018-12-31 Rp1.56 Trillion
≈ $91.54 Million
Rp239.83 Billion
≈ $14.05 Million
0.154x +123.89%
2017-12-31 Rp1.36 Trillion
≈ $79.87 Million
Rp93.47 Billion
≈ $5.48 Million
0.069x -27.13%
2016-12-31 Rp1.27 Trillion
≈ $74.26 Million
Rp119.25 Billion
≈ $6.99 Million
0.094x -92.36%
2015-12-31 Rp126.33 Billion
≈ $7.40 Million
Rp155.61 Billion
≈ $9.12 Million
1.232x +56.52%
2014-12-31 Rp134.25 Billion
≈ $7.87 Million
Rp105.66 Billion
≈ $6.19 Million
0.787x -15.91%
2013-12-31 Rp88.32 Billion
≈ $5.18 Million
Rp82.66 Billion
≈ $4.84 Million
0.936x --

About Prodia Widyahusada Tbk PT

JK:PRDA Indonesia Diagnostics & Research
Market Cap
$202.71 Million
Rp3.46 Trillion IDR
Market Cap Rank
#16258 Global
#207 in Indonesia
Share Price
Rp3690.00
Change (1 day)
+1.10%
52-Week Range
Rp2300.00 - Rp3720.00
All Time High
Rp8245.29
About

PT Prodia Widyahusada Tbk provides clinical laboratory services primarily in Indonesia. The company offers laboratory, genomic, non-laboratory, and panel test services. It also operates Prodia specialty clinics; and offers vaccination, doctor consultation, and home services. It serves to individuals, doctors, and corporate and partnerships. The company was founded in 1973 and is headquartered in … Read more